CD4 and COVID-19: The CD4+ TH1-lineage was similarly characterized by increased IFN- (type I and II) and interleukin (IL6, IL12, IL21) signaling in mild COVID-19 (Fig. 5l; Supplementary information, Fig. S4f, g).